Pharmaceutical company Roche: top drugs based on revenue 2015-2017

Selected top drugs of pharmaceutical company Roche from 2015 to 2017, based on revenue (in million Swiss francs)

The data displays pharmaceutical company Roche's selected top drugs from 2015 to 2017, based on revenue. Roche is one of the biggest global pharmaceutical companies and is based in Basel, Switzerland. In 2015, Avastin was the top performer generating revenues of almost 6.7 billion CHF.

MabThera/Rituxan 7045 7300 7388
Herceptin 6538 6782 7014
Perjeta 1445 1846 2196
Actemra/RoActemra 1432 1697 1926
Xolair 1277 1498 1742
Activase/TNKase 935 1108 1219
Kadcyla 769 831 914